A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer

A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer

The standard treatment of nonmuscle invasive bladder cancer (NMIBC) is transurethral resection of the tumors, followed by intravesical therapy (IT), which comprises a direct instillation of a solution of Bacillus Calmette-Gu_erin vaccine or chemotherapy into the bladder. However, the recurrence rate...

Full description

Bibliographic Details
Main Authors: Bellat, V. (Author), Choi, B.B (Author), Law, B. (Author), Michel, A.O (Author), Stokol, T. (Author), Thomas, C. (Author)
Format: Article
Language:English
Published: American Association for Cancer Research Inc. 2022
Subjects:
Adjuvants, Immunologic
animal
Animals
BCG vaccine
BCG Vaccine
bladder
bladder tumor
drug
human
Humans
immunological adjuvant
Mice
mouse
Neoplasm Invasiveness
Neoplasm Recurrence, Local
pathology
Pharmaceutical Preparations
quality of life
Quality of Life
tumor invasion
tumor recurrence
Urinary Bladder
Urinary Bladder Neoplasms
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items